Drugs News and Research

RSS

New drug tirzepatide equally effective in early-onset and later-onset type 2 diabetes

Tirzepatide is as effective at treating early-onset type 2 diabetes (T2D), a more aggressive form of the condition that normally responds less well to treatment, as it is at treating T2D diagnosed later in life, new research being presented at the Annual Meeting of the European Association for the Study of Diabetes (EASD) in Hamburg, Germany (2-6 Oct) has found.

4 Oct 2023

Oral lipid nanoparticle drug shows promise for preventing colitis-associated cancer in mice

An oral lipid nanoparticle drug prevents tumor development in mice, suggesting this is a promising drug formulation for preventing colitis-associated cancer, according to a study led by researchers in the Institute for Biomedical Sciences at Georgia State University.

4 Oct 2023

Experts to discuss if lasting remission from diabetes is feasible in real-world setting

At this year's Annual Meeting of the European Association for the Study of Diabetes (EASD) in Hamburg, Germany (2-6 Oct) experts will discuss if lasting remission from diabetes is feasible in the real-world setting.

4 Oct 2023

Research identifies characteristics linked with higher risk of sudden cardiac arrest in people with type 2 diabetes

New research being presented at the Annual Meeting of the European Association for the Study of Diabetes (EASD) in Hamburg, Germany (2-6 Oct) has identified a range of characteristics associated with a higher risk of sudden cardiac arrest in individuals with type 2 diabetes.

4 Oct 2023

Review of Oregon's assisted dying law finds significant data gaps

There are critical gaps in the data provided on doctor assisted deaths in Oregon, USA, amid rising numbers of participants, finds a review of the process over the past 25 years, published online in the journal BMJ Supportive & Palliative Care.

4 Oct 2023

Trametinib: Potential therapeutic game-changer for Alzheimer's disease

Researchers developed the ATRIVIEW® platform to screen for molecules that promote differentiation neural stem cells (NSCs).

4 Oct 2023

Octopus-inspired suction patch revolutionizes drug delivery, promising an injection-free future

Scientists develop an octopus sucker-inspired buccal mucosa suction patch, enhancing systemic absorption of macromolecular drugs. This innovative, non-invasive delivery platform, validated on porcine and human subjects, presents a potential alternative to intravenous injections for better drug bioavailability and patient compliance.

4 Oct 2023

Antiviral treatment emerges as a potential game-changer in curbing type 1 diabetes progression

New research from the University of Oslo reveals antiviral drugs could help preserve insulin production in children newly diagnosed with type 1 diabetes, potentially slowing down or even preventing the disease. The study, building on earlier findings linking enterovirus to type 1 diabetes, showed that antiviral treatment led to maintained insulin production, proposing a new therapeutic avenue to treat and mitigate the progression of type 1 diabetes.

3 Oct 2023

New drugs have increased survival rates for men with metastatic prostate cancer

Survival rates for men with metastatic prostate cancer have increased by an average of six months, something which coincides with the gradual introduction of 'dual treatment' since 2016.

3 Oct 2023

Could a Poria cocos extract be the key to conquering insomnia?

The study reveals that Poria cocos extract significantly improves sleep quality in insomniacs, increasing total sleep time and enhancing REM sleep duration. While promising, further investigations are needed to validate these findings and explore the effects of other active compounds within P. cocos.

3 Oct 2023

AI tool PARMESAN predicts drug-gene interactions for genetic disorders

To discover new treatments for genetic disorders, scientists need a thorough knowledge of prior literature to determine the best gene/protein targets and the most promising drugs to test.

3 Oct 2023

Study confirms effectiveness of Pooled Cohort Equation for assessing cardiovascular risk

A recent study based on real-world community patient data confirms the effectiveness of the Pooled Cohort Equation (PCE), developed by the American Heart Association and the American College of Cardiology in 2013.

3 Oct 2023

Research opens the door for better use of people's own immune system T cells to fight cancer

Using laboratory-grown cells from humans and genetically engineered mice, scientists at Johns Hopkins Medicine say they have evidence that modifying a specific protein in immune white blood cells known as CD8+ T cells can make the cells more robust, potentially opening the door for better use of people's own immune system T cells to fight cancer.

3 Oct 2023

New discovery could delay relapse in triple-negative breast cancer

A team of researchers at the Medical University of Vienna has discovered that dormant tumor cells surviving chemotherapy can be targeted through the inhibition of a specific protein called P-glycoprotein (P-gp).

3 Oct 2023

New analytical tool could lead to a cure for idiopathic pulmonary fibrosis

Using a new recipe for growing blood vessels from living lung tissue in the lab, a University of Virginia School of Engineering and Applied Science research team has developed an analytical tool that could lead to a cure for idiopathic pulmonary fibrosis, or IPF, a lung-destroying disease.

3 Oct 2023

More schools stock overdose reversal meds, but others worry about stigma

Last year, a student fell unconscious after walking out of a bathroom at Central High School in Pueblo, Colorado.

3 Oct 2023

Microglial states and their impact on Alzheimer's disease

Researchers examined 152,459 microglial transcriptomes from 443 individuals, identifying 12 transcriptional states and their relationship to Alzheimer's disease.

3 Oct 2023

Could seaweeds be the superfood and medicine of the future?

Researchers consolidate the diverse nutritional and medicinal benefits of seaweeds, touting their potential in food, nutraceuticals, and pharmaceuticals. The study also highlights challenges and opportunities in industrial applications, calling for more research to optimize extraction and refinement processes.

2 Oct 2023

Novel vaccine lowers LDL cholesterol independent of statins

The effectiveness of virus-like particle (VLP)-based vaccines targeting epitopes in the low-density lipoprotein (LDL) receptor.

2 Oct 2023

Unlocking hope for mitochondrial disorders with INTEGRA Biosciences’ electronic pipette

INTEGRA Biosciences’ VOYAGER adjustable tip spacing pipette to support their research on mitochondrial diseases.

From INTEGRA Biosciences 2 Oct 2023

Drugs News and Research

New drug tirzepatide equally effective in early-onset and later-onset type 2 diabetes

Oral lipid nanoparticle drug shows promise for preventing colitis-associated cancer in mice

Experts to discuss if lasting remission from diabetes is feasible in real-world setting

Research identifies characteristics linked with higher risk of sudden cardiac arrest in people with type 2 diabetes

Review of Oregon's assisted dying law finds significant data gaps

Trametinib: Potential therapeutic game-changer for Alzheimer's disease

Octopus-inspired suction patch revolutionizes drug delivery, promising an injection-free future

Antiviral treatment emerges as a potential game-changer in curbing type 1 diabetes progression

New drugs have increased survival rates for men with metastatic prostate cancer

Could a Poria cocos extract be the key to conquering insomnia?

AI tool PARMESAN predicts drug-gene interactions for genetic disorders

Study confirms effectiveness of Pooled Cohort Equation for assessing cardiovascular risk

Research opens the door for better use of people's own immune system T cells to fight cancer

New discovery could delay relapse in triple-negative breast cancer

New analytical tool could lead to a cure for idiopathic pulmonary fibrosis

More schools stock overdose reversal meds, but others worry about stigma

Microglial states and their impact on Alzheimer's disease

Could seaweeds be the superfood and medicine of the future?

Novel vaccine lowers LDL cholesterol independent of statins

Unlocking hope for mitochondrial disorders with INTEGRA Biosciences’ electronic pipette

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News